眼科学公司Guardion Health Sciences微粒化液体配方Lumega-Z对年龄相关性黄斑部视力疾病显示出临床效益;$BIOSIG TECHNOLOGIE(BSGM)$ BioSig科技公司成功记录消融过程所传到的清晰信号。 查看全文网页链接查看全文
用户48783635432019-05-10 13:21
【汇众医疗】生物技术股票前瞻:全球眼科学市场收入将于2022年高达260亿美元,$Guardion健康科学(GHSI)$ 眼科学公司Guardion Health Sciences微粒化液体配方Lumega-Z对年龄相关性黄斑部视力疾病显示出临床效益;$BIOSIG TECHNOLOGIE(BSGM)$ BioSig科技公司成功记录消融过程所传到的清晰信号。 查看...查看全文
用户48783635432019-02-22 11:09
【介绍几家电疗公司】预计2029年生物电子医药市场规模将超600亿美元
$BIOSIG TECHNOLOGIE(BSGM)$$Nuvectra(NVTR)$ $波士顿科学(BSX)$ BioSig是一家开发专用生物医学信号处理平台的医疗设备公司,最近宣布,公司成功地使用 PURE EP ™系统进行了第一例患者病例的治疗, FDA 已批准其专有信号采...查看全文
BioSig Technologies(BSGM.US)获Ascendiant Capital首次覆盖,给予买入评级,目标价5.00美元。 BioSig Technologies(BSGM.US)公司简介:BioSig Technologies Inc是一家医疗技术公司。该公司正在商业化一种专有的生物医学信号处理平台,该平台... 网页链接
$BIOSIG TECHNOLOGIE(BSGM)$ RW - Registration Withdrawal Request Filed: 2019-07-12 AccNo: 0001185185-19-000960 Size: 9 KB 网页链接
$BIOSIG TECHNOLOGIE(BSGM)$ 8-K - Current report Filed: 2019-07-08 AccNo: 0001185185-19-000952 Size: 20 KBItem 8.01: Other Events 网页链接
$BIOSIG TECHNOLOGIE(BSGM)$ EFFECT - Notice of Effectiveness Filed: 2019-06-24 AccNo: 9999999995-19-001421 Size: 1 KB 网页链接
$BIOSIG TECHNOLOGIE(BSGM)$ 8-K - Current report Filed: 2019-06-25 AccNo: 0001185185-19-000917 Size: 41 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 8.01: Othe...
$BIOSIG TECHNOLOGIE(BSGM)$ 8-K - Current report Filed: 2019-06-20 AccNo: 0001185185-19-000895 Size: 46 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$BIOSIG TECHNOLOGIE(BSGM)$ DEL AM - Delaying amendment Filed: 2019-06-04 AccNo: 0001185185-19-000849 Size: 10 KB 网页链接
$BIOSIG TECHNOLOGIE(BSGM)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2019-05-31 AccNo: 0001185185-19-000834 Size: 658 KB 网页链接
$BIOSIG TECHNOLOGIE(BSGM)$ 8-K - Current report Filed: 2019-05-22 AccNo: 0001185185-19-000800 Size: 50 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Fina...
$BIOSIG TECHNOLOGIE(BSGM)$ 10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-05-16 AccNo: 0001185185-19-000755 Size: 98 KB 网页链接
$BIOSIG TECHNOLOGIE(BSGM)$ EFFECT - Notice of Effectiveness Filed: 2019-05-06 AccNo: 9999999995-19-001010 Size: 1 KB 网页链接